相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antigen bivalency of antigen-presenting cell-targeted vaccines increases B cell responses
Daniela Maria Hinke et al.
CELL REPORTS (2022)
Pandemic Preparedness Against Influenza: DNA Vaccine for Rapid Relief
Tor Kristian Andersen et al.
FRONTIERS IN IMMUNOLOGY (2021)
Methods to improve the immunogenicity of plasmid DNA vaccines
Dalinda Eusebio et al.
DRUG DISCOVERY TODAY (2021)
Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains
Amanda L. Skarlupka et al.
JOURNAL OF VIROLOGY (2021)
The Human Antibody Response to the Influenza Virus Neuraminidase Following Infection or Vaccination
Madhusudan Rajendran et al.
VACCINES (2021)
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
Alec W. Freyn et al.
MOLECULAR THERAPY (2020)
ADNA Vaccine That Encodes an Antigen-Presenting Cell-Specific Heterodimeric Protein Protects against Cancer and Influenza
Ranveig Braathen et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection
Maryna C. Eichelberger et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Dendritic cell targeted Ccl3-and Xcl1-fusion DNA vaccines differ in induced immune responses and optimal delivery site
Anna Lysen et al.
SCIENTIFIC REPORTS (2019)
Enhanced germinal center reaction by targeting vaccine antigen to major histocompatibility complex class II molecules
Tor Kristian Andersen et al.
NPJ VACCINES (2019)
Influenza Hemagglutinin and Neuraminidase: Yin-Yang Proteins Coevolving to Thwart Immunity
Ivan Kosik et al.
VIRUSES-BASEL (2019)
Mucosal Immunity against Neuraminidase Prevents Influenza B Virus Transmission in Guinea Pigs
Meagan McMahon et al.
MBIO (2019)
Endocytosis Deficient Murine Xcl1-Fusion Vaccine Enhances Protective Antibody Responses in Mice
Arnar Gudjonsson et al.
FRONTIERS IN IMMUNOLOGY (2019)
Extending the Stalk Enhances Immunogenicity of the Influenza Virus Neuraminidase
Felix Broecker et al.
JOURNAL OF VIROLOGY (2019)
Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus
Ki-Hye Kim et al.
VIROLOGY (2019)
Fcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies
E. R. Job et al.
MBIO (2019)
The human antibody response to influenza A virus infection and vaccination
Florian Krammer
NATURE REVIEWS IMMUNOLOGY (2019)
Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies
Yao-Qing Chen et al.
CELL (2018)
Antibody Immunodominance: The Key to Understanding Influenza Virus Antigenic Drift
Meghan O. Altman et al.
VIRAL IMMUNOLOGY (2018)
NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?
Florian Krammer et al.
MBIO (2018)
Influenza A Virus Cell Entry, Replication, Virion Assembly and Movement
Dan Dou et al.
FRONTIERS IN IMMUNOLOGY (2018)
DNA VaccinesHow Far From Clinical Use?
Dominika Hobernik et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Broadened immunity against influenza by vaccination with computationally designed influenza virus N1 neuraminidase constructs
E. R. Job et al.
NPJ VACCINES (2018)
OThe Interplay between the Host Receptor and Influenza Virus Hemagglutinin and Neuraminidase
Lauren Byrd-Leotis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Targeting Influenza Virus Hemagglutinin to Xcr1+ Dendritic Cells in the Absence of Receptor-Mediated Endocytosis Enhances Protective Antibody Responses
Arnar Gudjonsson et al.
JOURNAL OF IMMUNOLOGY (2017)
A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza
Tor Kristian Andersen et al.
JOURNAL OF VIROLOGY (2017)
Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge
Alaina J. Mooney et al.
JOURNAL OF VIROLOGY (2017)
Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets
Gale E. Smith et al.
VIROLOGY (2017)
Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes
Teddy John Wohlbold et al.
NATURE MICROBIOLOGY (2017)
Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection
David J. DiLillo et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model
Matthew J. Memoli et al.
MBIO (2016)
DNA Vaccines Encoding Antigen Targeted to MHC Class II Induce Influenza-Specific CD8+ T Cell Responses, Enabling Faster Resolution of Influenza Disease
Laura Lambert et al.
FRONTIERS IN IMMUNOLOGY (2016)
Efficient vaccine against pandemic influenza: combining DNA vaccination and targeted delivery to MHC class II molecules
Gunnveig Grodeland et al.
EXPERT REVIEW OF VACCINES (2015)
Mouse and human FcR effector functions
Pierre Bruhns et al.
IMMUNOLOGICAL REVIEWS (2015)
Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection
Arnold S. Monto et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses
Wen-Chun Liu et al.
JOURNAL OF VIROLOGY (2015)
Advances in the development of influenza virus vaccines
Florian Krammer et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice
Teddy John Wohlbold et al.
MBIO (2015)
Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo
David J. DiLillo et al.
NATURE MEDICINE (2014)
DNA Vaccines: MHC II-Targeted Vaccine Protein Produced by Transfected Muscle Fibres Induces a Local Inflammatory Cell Infiltrate in Mice
Tom-Ole Lovas et al.
PLOS ONE (2014)
In the Shadow of Hemagglutinin: A Growing Interest in Influenza Viral Neuraminidase and Its Role as a Vaccine Antigen
Teddy John Wohlbold et al.
VIRUSES-BASEL (2014)
Conserved and host-specific features of influenza virion architecture
Edward C. Hutchinson et al.
NATURE COMMUNICATIONS (2014)
Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny
Martin Guilliams et al.
NATURE REVIEWS IMMUNOLOGY (2014)
DNA Vaccine that Targets Hemagglutinin to MHC Class II Molecules Rapidly Induces Antibody-Mediated Protection against Influenza
Gunnveig Grodeland et al.
JOURNAL OF IMMUNOLOGY (2013)
Antibody Correlates and Predictors of Immunity to Naturally Occurring Influenza in Humans and the Importance of Antibody to the Neuraminidase
Robert B. Couch et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Neuraminidase-Inhibiting Antibody Is a Correlate of Cross-Protection against Lethal H5N1 Influenza Virus in Ferrets Immunized with Seasonal Influenza Vaccine
Steven Rockman et al.
JOURNAL OF VIROLOGY (2013)
The Specificity of Targeted Vaccines for APC Surface Molecules Influences the Immune Response Phenotype
Gunnveig Grodeland et al.
PLOS ONE (2013)
A Vero Cell-Derived Whole-Virus H5N1 Vaccine Effectively Induces Neuraminidase-Inhibiting Antibodies
Richard Fritz et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines
Robert B. Couch et al.
VACCINE (2012)
Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice
Judith D. Easterbrook et al.
VIROLOGY (2012)
Targeted DNA vaccines for enhanced induction of idiotype-specific B and T cells
Agnete B. Fredriksen et al.
FRONTIERS IN ONCOLOGY (2012)
DNA vaccines: an historical perspective and view to the future
Margaret A. Liu
IMMUNOLOGICAL REVIEWS (2011)
Influenza neuraminidase-inhibiting antibodies are induced in the presence of zanamivir
Ishrat Sultana et al.
VACCINE (2011)
Defective Ribosomal Products Are the Major Source of Antigenic Peptides Endogenously Generated from Influenza A Virus Neuraminidase
Brian P. Dolan et al.
JOURNAL OF IMMUNOLOGY (2010)
Recombinant Soluble, Multimeric HA and NA Exhibit Distinctive Types of Protection against Pandemic Swine-Origin 2009 A(H1N1) Influenza Virus Infection in Ferrets
Berend Jan Bosch et al.
JOURNAL OF VIROLOGY (2010)
Recombinant influenza B virus HA and NA antigens administered in equivalent amounts are immunogenically equivalent and induce equivalent homotypic and broader heterovariant protection in mice than conventional and live influenza vaccines
Bert E. Johansson et al.
HUMAN VACCINES (2008)
Chemokine-idiotype fusion DNA vaccines are potentiated by bivalency and xenogeneic sequences
Agnete Brunsvik Fredriksen et al.
BLOOD (2007)
Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans
Matthew R. Sandbulte et al.
PLOS MEDICINE (2007)
DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells
AB Fredriksen et al.
MOLECULAR THERAPY (2006)
Immunization against influenza A virus: Comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system
IC Brett et al.
VIROLOGY (2005)
Estimation of the neuraminidase content of influenza viruses and split-product vaccines by immunochromatography
T Tanimoto et al.
VACCINE (2005)
Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expres sing DNAs by electroporation
JJ Chen et al.
VACCINE (2005)
Covalent antibody display - an in vitro antibody-DNA library selection system
H Reiersen et al.
NUCLEIC ACIDS RESEARCH (2005)
Supplementation of conventional trivalent influenza vaccine with purified viral N1 and N2 neuraminidases induces a balanced immune response without antigenic competition
BE Johansson et al.
VACCINE (2002)
Viral neuraminidase treatment of dendritic cells enhances antigen-specific CD8+ T cell proliferation, but does not account for the CD4+ T cell independence of the CD8+ T cell response during influenza virus infection
S Oh et al.
VIROLOGY (2001)
Dendritic cell regulation of T(H)1-T(H)2 development
M Moser et al.
NATURE IMMUNOLOGY (2000)
分享论文
